Veru Inc. Files Additional Proxy Materials

Ticker: VERU · Form: DEFA14A · Filed: Jun 20, 2024 · CIK: 863894

Sentiment: neutral

Topics: proxy-filing, regulatory, pharmaceutical

Related Tickers: VERU

TL;DR

VERU filed more proxy docs, shareholders get updated info.

AI Summary

Veru Inc. filed a Definitive Additional Materials proxy statement on June 20, 2024. This filing relates to the company's Schedule 14A, indicating it's providing supplementary information to shareholders. The company, formerly known as The Female Health Co. and Wisconsin Pharmacal Company Inc., is incorporated in Wisconsin and operates in the Pharmaceutical Preparations industry.

Why It Matters

This filing provides shareholders with updated or additional information relevant to upcoming shareholder votes or decisions, ensuring they have the most current details for informed participation.

Risk Assessment

Risk Level: low — This is a routine filing of additional proxy materials, not indicating any immediate financial distress or significant corporate event.

Key Players & Entities

FAQ

What type of SEC filing is this?

This is a DEFA14A filing, specifically marked as Definitive Additional Materials.

When was this filing made?

The filing was made on June 20, 2024.

What is Veru Inc.'s primary industry?

Veru Inc. operates in the Pharmaceutical Preparations industry, with SIC code 2834.

Has Veru Inc. operated under different names previously?

Yes, Veru Inc. was formerly known as The Female Health Co. and Wisconsin Pharmacal Company Inc.

Where is Veru Inc. incorporated?

Veru Inc. is incorporated in Wisconsin (WI).

Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-06-20 07:33:25

Key Financial Figures

Filing Documents

From the Filing

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under 240.14a-12 VERU INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of filing fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. VERU INC. SUPPLEMENT TO THE PROXY STATEMENT FOR THE ADJOURNED ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 27, 2024 This Supplement dated June 19, 2024 amends and supplements the Amended Proxy Statement of Veru Inc. (we or Veru) dated May 9, 2024 (the Proxy Statement), with the following information. Adjournment of Annual Meeting On June 18, 2024, we announced that we have adjourned our 2024 Annual Meeting of Shareholders (the Annual Meeting) due to the lack of a required quorum. The Annual Meeting has been adjourned to Thursday, June 27, 2024, at 9:00 a.m., local time, at 2916 N. Miami Avenue, Suite 1000, Miami, Florida 33127, with respect to all proposals described in the Proxy Statement. Appointment of Proxy Solicitor We have hired Morrow Sodali LLC to solicit proxies with respect to the Annual Meeting. We will pay Morrow Sodali LLC a fee of $10,000, plus reasonable expenses. Morrow Sodali LLC will, among other things, provide advice regarding proxy solicitation issues and solicit proxies from our shareholders on our behalf in connection with the Annual Meeting. Important Information Veru has filed a definitive Proxy Statement with the Securities and Exchange Commission (SEC) and has furnished to its shareholders a Proxy Statement in connection with the solicitation of proxies for the Annual Meeting. Veru advises its shareholders to read the Proxy Statement relating to the Annual Meeting, as amended and supplemented by this Supplement, because it contains important information. Except as described in this supplement, none of the items or information presented in the Proxy Statement is affected by this supplement. This supplement does not provide all of the information that is important to your voting decisions at the Annual Meeting. The Proxy Statement contains other important additional information. We encourage you to carefully read this supplement together with the Proxy Statement. Your vote is important , no matter how many or how few shares you may own. If you have not already done so, please vote TODAY by telephone, via the Internet, or by signing, dating and returning the proxy card or voting instruction card previously mailed to you. If you have already returned your proxy or voting instruction card or voted by telephone or via Internet, you do not need to take any action unless you wish to change your vote. 2

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing